Avaxim

Avaxim is a vaccine designed to prevent hepatitis A, a viral liver infection. It contains inactivated hepatitis A virus and is administered via intramuscular or subcutaneous injection.

Avaxim is primarily used for the prevention of hepatitis A, a contagious liver disease caused by the hepatitis A virus. It is often recommended for individuals traveling to regions with high rates of hepatitis A or for those at increased risk of exposure. The vaccine works by stimulating the body's immune system to produce antibodies against the virus, providing protection against future infection.

Common effects of Avaxim may include mild soreness, redness, or swelling at the injection site. Some individuals might experience mild fever, headache, or fatigue following vaccination. These effects are generally short-lived and resolve on their own without treatment.

Avaxim should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any current medications or health conditions before receiving the vaccine.

Avaxim may interact with certain medications or other vaccines. It is advisable to consult a healthcare professional before receiving Avaxim if you are taking any other medications or have recently received other vaccines. Alcohol consumption does not typically affect the vaccine's efficacy, but it is always best to follow the advice of a healthcare provider.